Inflammatory Myofibroblastic Tumor
Differential Diagnosis
- Sclerosing inflammatory lesions (retroperitonitis, mesenteritis, mediastinitis, cholangitis, pancreatitis)
- Nodular fasciitis
- Infantile desmoid fibromatosis
- Adult fibromatoses
- Gastrointestinal stromal tumor
- Inflammatory fibroid polyp (GI tract)
- Smooth muscle tumor
- Inflammatory MFH
- Myofibroma
- Dedifferentiated liposarcoma
- Inflammatory pseudotumor of spleen and lymph node
- Pseudosarcomatous myofibroblastic proliferation of GU tract
- Follicular dendritic cell neoplasm
- Interdigitating dendritic cell sarcoma
Sclerosing Inflammatory Lesions (Retroperitonitis, Mesenteritis, Mediastinitis, Cholangitis, Pancreatitis) | Inflammatory Myofibroblastic Tumor |
---|---|
Diffuse, typically no distinct mass | Circumscribed mass lesion |
Rare in children | Usually in children |
IgG4 serum levels and plasma cells increased | No association with IgG4 |
Inflammatory Myofibroblastic Tumor | Nodular Fasciitis |
---|---|
Frequently over 5 cm | Rarely over 5 cm |
Usually in children | Rare in children |
Frequently involves abdominal cavity | Does not involve abdominal cavity |
Variable patterns | Usually loose pattern throughout |
Prominent inflammatory cells | Only scattered inflammatory cells |
Inflammatory Myofibroblastic Tumor | Infantile Fibromatosis |
---|---|
Frequent in abdomen | Rare in abdomen |
Usually age 0-14 years | Age <5 years |
Prominent inflammation | Variable, peripheral inflammation |
Variable locations | Centered in muscle |
Fibromatosis, Abdominal Desmoid, Extra-abdominal Desmoid, Mesenteric, Retroperitoneal and Pelvic | Inflammatory Myofibroblastic Tumor |
---|---|
Rare <12 years of age | Age usually <14, rare >30 |
Inflammation not prominent | Prominent inflammation, particularly plasma cells |
Alk1 negative | Alk1 frequently positive |
Beta catenin 80-90% | Beta catenin negative |
Inflammatory Myofibroblastic Tumor | Gastrointestinal Stromal Tumor |
---|---|
Usually in children | Rare in children |
Frequently associated with systemic signs and symptoms | Not associated with systemic signs and symptoms |
Prominent inflammatory cells | Usually only scattered inflammatory cells |
Frequently positive for desmin, keratin and ALK | Desmin, keratin and ALK negative |
CD117, DOG1, CD34 negative | CD117 74-95%, DOG1 87-95%, CD34 70% |
Inflammatory Fibroid Polyp | Inflammatory Myofibroblastic Tumor |
---|---|
Systemic signs and symptoms absent | Systemic signs and symptoms frequent |
Infrequent involvement of muscularis propria | Frequent involvement of muscularis propria |
Eosinophils predominate | Plasma cells usually predominate |
Concentric onion skin like pattern around vessels and glands is frequent | Lacks concentric onion skin pattern |
Not associated with lymphadenopathy | May have reactive regional lymphadenopathy |
Inflammatory Myofibroblastic Tumor | Leiomyosarcoma of Soft Tissue |
---|---|
Usually <14 years, rare >30 years | Rare under 12 years |
Chronic inflammation usual | Infrequent inflammation |
Inflammatory Malignant Fibrous Histiocytoma | Inflammatory Myofibroblastic Tumor |
---|---|
Mean age 50, wide range | Usually <14 years, rare >30 years |
Sheets of neutrophils | Mixed or lymphocyte predominant inflammation |
Marked cytologic atypia | Absent or mild atypia |
Myofibroma | Inflammatory Myofibroblastic Tumor |
---|---|
90% <2 years | Usually age 0-14 years |
Biphasic nodules with immature cells | No immature cells |
Hemangiopericytomatous vessels | No HPC like vessels |
Rare in abdomen | Frequent in abdomen |
Dedifferentiated Liposarcoma | Inflammatory Myofibroblastic Tumor |
---|---|
High grade nonlipogenic comoponent present | Lacks significant cytologic atypia |
Atypical lipomatous tumor component present | Lacks lipomatous component |
Inflammatory Myofibroblastic Tumor | Inflammatory Pseudotumor of Lymph Node and Spleen |
---|---|
ALK positive 35-60% | ALK negative |
EBV negative | EBV may be positive |
Rare in lymph node and spleen | Occurs in lymph node and spleen |
In the GU tract some consider the following to be separate entities while others consider them to be the same lesion
Inflammatory Myofibroblastic Tumor | Pseudosarcomatous Myofibroblastic Proliferation of GU Tract |
---|---|
Prominent lymphoplasmacytic infiltrate | Lacks prominent plasma cells |
Frequent storiform and fibrous areas | Lacks storiform and fibrous areas |
Pale eosinophilic cytoplasm on spindle cells | Intensely eosinophilic cytoplasm on spindle cells |
Inflammatory Myofibroblastic Tumor | Follicular Dendritic Cell Neoplasm |
---|---|
Rarely involves lymph node or spleen | Frequently involves lymph node and spleen |
ALK positive 35-60% | ALK negative |
CD21, CD23, CD35 negative | CD21, CD23 or CD35 positive |
EBV negative | EBV positive by in situ hybridization |
Inflammatory Myofibroblastic Tumor | Interdigitating Dendritic Cell Sarcoma |
---|---|
ALK positive 35-60% | ALK negative |
S100 negative | S100 positive |